Atlantic Family Wealth LLC Invests $262,000 in Sanofi (NASDAQ:SNY)

Atlantic Family Wealth LLC bought a new position in shares of Sanofi (NASDAQ:SNY) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 5,431 shares of the company’s stock, valued at approximately $262,000.

Several other hedge funds and other institutional investors have also made changes to their positions in SNY. Allspring Global Investments Holdings LLC increased its position in Sanofi by 434.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 50,583 shares of the company’s stock worth $2,915,000 after buying an additional 41,117 shares during the period. Foundations Investment Advisors LLC purchased a new stake in shares of Sanofi in the third quarter valued at approximately $248,000. Private Advisor Group LLC boosted its stake in shares of Sanofi by 2.6% in the third quarter. Private Advisor Group LLC now owns 52,338 shares of the company’s stock valued at $3,016,000 after buying an additional 1,339 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Sanofi in the third quarter valued at approximately $7,038,000. Finally, Brighton Jones LLC purchased a new stake in Sanofi during the third quarter worth $205,000. Institutional investors and hedge funds own 14.04% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on SNY shares. StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Sanford C. Bernstein upgraded Sanofi to a “strong-buy” rating in a research report on Thursday, January 30th. Finally, Deutsche Bank Aktiengesellschaft upgraded Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. Two research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $60.00.

Sanofi Stock Up 0.6 %

Shares of NASDAQ:SNY opened at $54.46 on Friday. The company has a market capitalization of $138.21 billion, a P/E ratio of 21.87, a P/E/G ratio of 1.01 and a beta of 0.57. The stock’s fifty day simple moving average is $50.95 and its 200-day simple moving average is $52.53. Sanofi has a 52-week low of $45.22 and a 52-week high of $58.97. The company has a quick ratio of 1.14, a current ratio of 1.46 and a debt-to-equity ratio of 0.15.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, meeting the consensus estimate of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. As a group, equities research analysts forecast that Sanofi will post 4.36 earnings per share for the current fiscal year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.